Ken Griffin's position in Sarepta Therapeutics is currently worth $24.8 Million. That's 0.02% of their equity portfolio (732nd largest holding). The first Sarepta Therapeutics trade was made in Q2 2013. Since then Ken Griffin bought shares 55 more times and sold shares on 48 occasions. The stake costed the investor $16.4 Million, netting the investor a gain of 51% so far.